Antibiotic use in two cohorts of German intensive care units

Journal of Hospital Infection

Volumn 64, Issue 3, 2006, Pages 231-237

  de With, K ^a   Meyer, E ^a   Steib Bauert, M ^a   Schwab, F ^b   Daschner, F D ^a   Kern, W V ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antibiotic use; Intensive care medicine; Pharmacoepidemiology

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; MACROLIDE; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COHORT ANALYSIS; DATA ANALYSIS; DRUG CLASSIFICATION; DRUG DOSE REGIMEN; GERMANY; HEALTH SURVEY; HOSPITAL; HUMAN; INFECTION; INTENSIVE CARE UNIT; PRESCRIPTION; UNIVERSITY HOSPITAL; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION REVIEW; EPIDEMIOLOGIC METHODS; GERMANY; HOSPITAL BED CAPACITY; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; PHARMACOEPIDEMIOLOGY;

EID: 33749242978     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.05.018     Document Type: Article

References (34)

1. Gaynes R. The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals. Infect Dis Clin North Am 11 (1997) 757-765
2. Kollef M.H. Optimizing antibiotic therapy in the intensive care unit setting. Crit Care 5 (2001) 189-195
3. Niederman M.S. Appropriate use of antimicrobial agents: challenges and strategies for improvement. Crit Care Med 31 (2003) 608-616
4. Carlet J., Ben Ali A., and Chalfine A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis 17 (2004) 309-316
5. Warren M.M., Gibb A.P., and Walsh T.S. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital. J Hosp Infect 59 (2005) 90-95
6. Glowacki R.C., Schwartz D.N., Itokazu G.S., Wisniewski M.F., Kieszkowski P., and Weinstein R.A. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis 37 (2003) 59-64
7. Gentry C., Flournoy D.J., and Reinert R. Analysis of antimicrobial resistance among gram-negative bacilli and antimicrobial use in intensive care unit patients for 5 years in a Veterans Affairs medical center. Am J Infect Control 30 (2002) 411-416
8. Lemmen S.W., Hafner H., Kotterik S., Lutticken R., and Topper R. Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens. Infection 28 (2000) 384-387
9. Kumarasamy Y., Cadwgan T., Gillanders I.A., Jappy B., Laing R., and Gould I.M. Optimizing antibiotic therapy - the Aberdeen experience. Clin Microbiol Infect 9 (2003) 406-411
10. Erbay A., Bodur H., Akinci E., and Colpan A. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect 59 (2005) 53-61
11. McDonald L.C., Yu H.T., Yin H.C., et al. Correlates of antibiotic use in Taiwan hospitals. Infect Control Hosp Epidemiol 22 (2001) 565-571
12. Bergmans D.C., Bonten M.J., Gaillard C.A., et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 39 (1997) 527-535
13. Malacarne P., Rossi C., and Bertolini G. Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study. J Antimicrob Chemother 54 (2004) 221-224
14. Kitzes-Cohen R., Koos D., and Levy M. Patterns of systemic antibiotic use in a tertiary hospital in Israel in the years 1998-2000. Int J Clin Pharmacol Ther 42 (2004) 246-252
15. Walther S.M., Erlandsson M., Burman L.G., et al. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand 46 (2002) 1075-1081
16. Sintchenko V., Iredell J.R., Gilbert G.L., and Coiera E. Handheld computer based decision support reduces patient length of stay and antibiotic prescribing in critical care. J Am Med Inform Ass 12 (2005) 398-402
17. Monnet D.L., Archibald L.K., Phillips L., Tenover F.C., McGowan Jr. J.E., and Gaynes R.P. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Infect Control Hosp Epidemiol 19 (1998) 388-394
18. Naaber P., Koljalg S., and Maimets M. Antibiotic usage and resistance - trends in Estonian university hospitals. Int J Antimicrob Agents 16 (2000) 309-315
19. Hermosilla Najera L., Canut B.A., Ulibarrena S.M., Abasolo Osinaga E., and Abecia Inchaurregui L.C. Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period. Pharmacoepidemiol Drug Saf 12 (2003) 243-247
20. Kiivet R.A., Dahl M.L., Llerena A., Maimets M., Wettermark B., and Berecz R. Antibiotic use in three European university hospitals. Scand J Infect Dis 30 (1998) 277-280
21. Petersen I.S., Hesselbjerg L., Jorgensen L., et al. High antibiotic consumption in Danish intensive care units?. APMIS 107 (1999) 989-996
22. Dollman C.M., and Cooper C.M. State-wide surveillance of in-hospital antimicrobial utilisation in South Australia. Commun Dis Intell 27 Suppl. (2003) S19-S27
23. Ramsay C., Brown E., Hartman G., et al. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 52 (2003) 764-771
24. Parrino T.A. Controlled trials to improve antibiotic utilization: a systematic review of experience, 1984-2004. Pharmacotherapy 25 (2005) 289-298
25. Meyer E., Jonas D., Schwab F., Rueden H., Gastmeier P., and Daschner F.D. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31 (2003) 208-215
26. Meyer E., Schwab F., Jonas D., Rueden H., Gastmeier P., and Daschner F.D. Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med 30 (2004) 1089-1096
27. Meyer E., Schwab F., Jonas D., Rueden H., Gastmeier P., and Daschner F.D. Antibiotic use and bacterial resistance in German intensive care units: data from project SARI from 2000 to 2004. In: Abstracts of the Fifteenth European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen. Clin Microbiol Infect 11 Suppl. 2 (2005) 329 [Abstract P1058]
28. Kern W.V., Rose A.D., Hay B., Muche R., and Frank U. Antimicrobial expenditures and usage at four university hospitals. Infection 29 (2001) 127-137
29. de With K., Schröder H., Meyer E., et al. Antibiotikaanwendung in Deutschland im europäischen Vergleich. Dtsch Med Wochenschr 129 (2004) 1987-1992
30. de With K., Bergner J., Bühner R., et al. Antibiotic use in German university hospitals 1998-2000 (project INTERUNI-II). Int J Antimicrob Agents 24 (2004) 213-218
31. Kern W.V., de With K., Steib-Bauert M., et al. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002. Infection 33 (2005) 333-339
32. de With K., Bergner J., Bühner R., et al. Antibiotikaanwendung an deutschen Hochschulkliniken (Projekt INTERUNI-II) - Ergebnisse für medizinische Kliniken unter Berücksichtigung von Intensivpflegestationen, onkologischen Stationen und sonstigen Pflegebereichen. Med Klin 99 (2004) 347-354
33. Kern W.V. Medical antibiotic use surveillance networks in Germany. In: Abstracts of the Fifteenth European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen. Clin Microbiol Infect 11 Suppl. 2 (2005) 32 [Abstract S134]
34. Fridkin S.K., Steward C.D., Edwards J.R., et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Clin Infect Dis 29 (1999) 245-252